(Washington, D.C.) — As the debate on prescription drugs continues and policymakers seek solutions to reduce out-of-control prices for Texas consumers, the Pharmaceutical Care Management Association (PCMA) today is announcing the launch of a new, multi-faceted digital public affairs campaign
Christina Perkins Manager, Accounting Christina Perkins is Manager of Accounting at PCMA. In this role, she helps to maintain the company’s financials. Christina has over fifteen years of experience in accounting, holding various positions throughout her career. Christina most recently
Welcome to the Pharmacy Benefit Brief. This brief is your monthly snapshot of news from America’s prescription drug supply chain including pharmacy benefit managers, independent pharmacies, and drug manufacturers. All that Glitters is Not Gold… It’s true,
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) will hold its annual “PBM Policy Forum” tomorrow, April 19, at the Newseum in Washington, D.C. This year’s event features subject matter experts explaining key issues in the drug supply chain
Executive Vice President CVS Health and President CVS Caremark, and PCMA Chairman of the Board David Joyner is executive vice president of CVS Health and president of CVS Caremark. He leads the Pharmacy Services segment, which provides solutions to employers,
In case you missed it, Jason Altmire, former Democratic three-term U.S. Representative from Pennsylvania and current adjunct professor at Texas Tech University, explains why so-called “delinking” proposals would be catastrophic for patients and families’ pocketbooks in an op-ed in RealClearHealth.
In case you missed it, Jason Altmire, former Democratic three-term U.S. Representative from Pennsylvania and current adjunct professor at Texas Tech University, explains why so-called “delinking” proposals would be catastrophic for patients and families’ pocketbooks in a new op-ed in
A wide array of voices from across the country are calling on lawmakers to oppose recently reintroduced legislation, the Pharmacy Benefit Manager Transparency Act (S.127), which fundamentally misconstrues the role of pharmacy benefit companies, unfairly proposes to take away employers’
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) today issued the following statement on litigation, filed in the U.S. District Court of the District of Columbia, regarding the Trump administration’s final rule Transparency in Coverage: To avoid higher prescription drug costs for
Welcome to the Pharmacy Benefit Brief. This brief is your monthly snapshot of news from America’s prescription drug supply chain including pharmacy benefit managers, independent pharmacies, and drug manufacturers. THE GREAT DISPENSING DEBATE… Among ways that pharmacists are paid
©2024 PCMA. All Rights Reserved.
